comparemela.com

Latest Breaking News On - Nasdaq akya - Page 1 : comparemela.com

Kent Lake Capital LLC Sells 629,686 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA)

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […]

United-states
America
Brian-mckelligon
Akoya-biosciences
Asia-pacific
Blackrock-inc
Nasdaq
Unisuper-management-pty-ltd
Kennedy-capital-management
Kent-lake-capital
Canaccord-genuity-group
Akoya-biosciences-inc

Akoya Biosciences Announces Preliminary Financial Results

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced.

Brian-mckelligon
Akoya-bioscience
Priyam-shah
Akoya-biosciences
Nasdaq
Spatial-biology-company
Exchange-commission
Akoya-biosciences-inc
Chief-executive-officer
Financial-condition
Nasdaq-akya
Akoya-biosciences

Akoya Biosciences Deploys the MaxFuse Algorithm

MaxFuse enables matching and integration of datasets from spatial proteomics, spatial transcriptomics, single-cell sequencing, or other modalities .

Nancy-zhang
Priyam-shah
Akoya-bioscience
Garry-nolan
Aaron-mayer
Akoya-biosciences
Zongming-ma
Akoya-biosciences-inc
University-of-pennsylvania
Exchange-commission
Spatial-biology-company
Nasdaq

Insider Selling: Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Sells 7,500 Shares of Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $4.48, for a total value of $33,600.00. Following the completion of the transaction, the chief executive officer now owns 152,563 shares […]

United-states
America
American
Asia-pacific
Brian-mckelligon
Piper-sandler
Akoya-biosciences
Morgan-stanley
Charles-schwab-investment-management-inc
Akoya-biosciences-company-profile
American-international-group-inc
Investment-counsel-inc

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares of Stock

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of Akoya Biosciences stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $4.48, for a total transaction of $33,600.00. Following the transaction, the chief executive officer now owns 152,563 shares in the company, […]

United-states
America
Brian-mckelligon
Akoya-biosciences
Piper-sandler
Asia-pacific
Akoya-biosciences-inc
Akoya-biosciences-company-profile
Morgan-stanley
Peddock-capital-advisors
Nasdaq
Unisuper-management-pty-ltd

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.